SomnoMed Limited
Research SomnoMed Limited (SOM.AX) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerSOM.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Financial periodFY2026
- RevenueAUD 114.53M
- Revenue growth25.0%
- Net income-AUD 2.65M
- Free cash flowAUD 2.54M
- Gross margin61.1%
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | AUD 114.53M | -AUD 2.65M | AUD 2.54M | 61.1% | -0.01 | AUD 17.18M | AUD 5.46M | AUD 47.40M |
| FY2024 | AUD 91.65M | -AUD 12.24M | -AUD 11.67M | 60.2% | -0.1 | AUD 16.18M | AUD 6.72M | AUD 45.91M |
| FY2023 | AUD 83.62M | -AUD 8.00M | -AUD 10.29M | 62.1% | -0.08 | AUD 11.96M | AUD 23.82M | AUD 24.51M |
| FY2022 | AUD 72.58M | -AUD 4.44M | -AUD 6.93M | 61.0% | -0.04 | AUD 15.64M | AUD 16.89M | AUD 27.79M |
| FY2021 | AUD 62.71M | -AUD 1.19M | -AUD 1.43M | 60.2% | -0.01 | AUD 21.11M | AUD 8.91M | AUD 32.16M |
About SomnoMed Limited
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. The company offers SomnoDent, such as SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, herbst advance, and SomnoDent Fusion for the treatment of obstructive sleep apnea. It also provides SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position;
Related stock research
Other Healthcare stocks
Frequently asked questions
What does SomnoMed Limited do?
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. The company offers SomnoDent, such as SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, herbst advance, and SomnoDent Fusion for the treatment of obstructive sleep apnea.